Ozempic and Metformin target different but complementary pathways in managing blood sugar levels. Ozempic, a GLP-1 receptor agonist, activates receptors that promote insulin secretion. This process is glucose-dependent, meaning it only triggers insulin release when blood sugar rises. It also slows gastric emptying, leading to decreased appetite and enhanced satiety….